Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of cannabinoids in the treatment of multiple myeloma

Use of cannabinoids in the treatment of multiple myeloma

US Patent 11065227 · Granted Jul 20, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

7-OH-cannabidiol (7-OH-CBD) and/or 7-OH-cannabidivarin (7-OH-CBDV) for use in th2023
Use of cannabinoids in the treatment of epilepsy2023
Use of cannabinoids in the treatment of inflammatory skin diseases2022
7-OH-cannabidiol (7-OH-CBD) and/or 7-OH-cannabidivarin (7-OH-CBDV) for use in th2021
Use of cannabinoids in the treatment of epilepsy2021
Use of tetrahydrocannabinol and/or cannabidiol for increasing radiosensitivity i2020
Cannabinoids for use in the treatment of neurodegenerative diseases or disorders2019
Use of cannabinoids in the treatment of degenerative skeletal muscle diseases2019
Use of phytocannabinoids in the treatment of ovarian carcinoma2018
7-hydroxy cannabidiol (7-OH-CBD) for use in the treatment of non-alcoholic fatty2018
Active pharmaceutical ingredient (API) comprising cannabinoids for use in the tr2018
Cannabinoids for use in the treatment of neuropathic pain2018